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The study aims to inform potential cost-effectiveness analysis of hypertension management
in Vietnam by providing utilities and predictors of utilities in patients with hypertension.
Methods
Hypertensive patients up to 80 years old visiting the hospital were invited to participate in a
survey using Quality Metric’s Short-form 36v2TM translated into Vietnamese. Health-state
utilities were estimated by applying a previously published algorithm.
Results
The mean utility of the 691 patients interviewed was 0.73. Controlling for age, sex, blood
pressure (BP) stage, and history of stroke, the utilities in older patients were lower than
those in younger ones, and statistically significantly different between the extremes of youn-
gest and oldest groups (p = 0.03). Utility in males was higher than in females (p = 0.002). As
expected, patients with a history of stroke appeared to exhibit lower utilities than patients
without such history, but the difference was not statistically significant (p = 0.73). Patients
with more than three comorbidities did have lower utilities than patients without comorbidity
(p = 0.01).
Conclusions
Health-state utilities found among hypertensive patients in Vietnam were similar to those
found in other international studies. It is suggested that lower of health-state utilities exist
among those patients who were older, female or had more than three comorbidities in com-
parison with respective reference groups. However, further research for confirmation is
required. The data from this study provide a potential reference on health-state utilities of
hypertensive patients in Vietnam as an input for future cost-effectiveness analysis of
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interventions. Also, it may serve as a reference for other similar populations, especially in
the context of similar environments in low income countries.
Introduction
Hypertension and its complications represent key public health problems around the world
especially among older adults. More than 40% of hypertensive person are older than 25 years
[1]. Every year, 9.4 million deaths occur due to complications of hypertension [2]. Globally,
diagnosis and treatment are relatively accessible and affordable, but even when patients are on
treatment, there are health risks in the long term.
Different outcome measures can be applied to assess the effects of diagnosis and treatment,
including health-state utilities, which are also core inputs for cost–effectiveness analysis of dis-
ease management. Notably, detailed measurements of utilities of hypertensive patients can sup-
port health economic evaluations of planned hypertension management programs. Currently,
only limited information on health-state utilities of hypertensive patients is available for Asian
countries, including Vietnam.
In many countries, the Short-form 36 version 2TM (SF-36v2) questionnaire, as developed by
Quality Metrics, has been applied to collect data on health-related quality of life (HRQoL) [3].
This instrument has also been applied for hypertensive patients in various countries [4–11],
enhancing plausibility and acceptability of cross-country comparisons of HRQoL [9, 12, 13]. In
Asia this instrument has already been validated in China, Singapore, Korea and the Philippines
[14–17] which enhances plausibility that it is suitable for use in Vietnam.
In this study, we useSF-36v2TM data from patients visiting a hospital out-patient clinic in an
urban setting in Northern Vietnam to measure their HRQoL expressed in utilities. Further-
more, we aim to evaluate differences in health-state utilities related to characteristics of these
patients to identify potential predictors.
Methods
Setting
We conducted the survey from April to May 2013 among patients attending the hypertension
unit of the outpatient clinic in Thai Nguyen General Hospital; further details are described else-
where [18]. The patients included new and existing cases coming to the outpatient clinic for
the management of their hypertension.
Participants
All confirmed hypertensive patients who were able to read and write, were no more than 80
years old and were willing to participate in this study were recruited. We invited patients to
take the survey while they were waiting for examination; interviewers collected the data in the
outpatient clinic. As one of our purposes was to investigate the relation between utilities and
different patient characteristics, only records with full information were included in the analy-
sis. Among 722 cases agreed to provide data, 712 records had full information on patients’
characteristic. Finally, 691 cases were complete and could be used to calculate health utility.
Procedures and measurements
Five researchers of Thai Nguyen University of Medicine and Pharmacy were trained to inter-
view patients. Notably, interviewers were trained in basic interview skills and structuring the
interview in line with the contents of questionnaire. There was a practice section to make sure
Vietnamese Utilities in Hypertension
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they have similar understanding and consistent applications of the questionnaire. Currently,
only scare evidence and recommendation exist on what methods to use for measuring health
utilities specially among hypertensive population. Notably, the algorithm produced by Brazier
et al. used original valuation of SF-36v2TM data, without potential errors related to mapping
[19]. This model has also previously been shown to explain a reasonable share of variance
(approximately 60%) and is considered sensitive in the measurement of impacts on health,
especially in those cases when only relatively small differences in health are expected [19], as in
the case of hypertension management. Given these advantages, this model was used to estimate
health utilities based on SF-36v2TM data in this study.
We applied the Quality Metric Short Form, SF-36v2TM, translated into Vietnamese, to col-
lect data on health status. Health-state utilities were estimated by applying the previous derived
algorithm [19]. For this model, eleven specific items of SF-36 were selected to estimate health-
state utilities: in the physical domain, items number 3, 4 and 12 were included; in the role
domain, items number 15 and 18; item number 32 in the social domain; items number 21 and
22 in the pain domain; items number 24 and 28 in the mental domain; and item number 27 in
the vitality domain. Utilities were subsequently estimated based on responses elicited by stan-
dard gambling techniques [19]. Several steps to obtain health utilities values within the algo-
rithm are presented in S1 Appendix.
During interviews we collected data on patient characteristics such as age, gender, occupa-
tion and ethnicity. Blood pressure (BP) was measured once at the time of the medical examina-
tion. Other health status parameters were collected from hard copies of medical records,
including comorbidities such as diabetes, gout, heart valve disease, peripheral artery disease,
chronic arthritis, lipid metabolism disorder, coronary artery disease, other chronic diseases,
and history of stroke as a complication of hypertension.
Statistical analysis
Descriptive listings, including percentages, frequencies, means and SDs for the various groups
distinguished, were computed. We also applied independent t-tests, one-way ANOVA test to
test the significance of differences in mean utilities between groups. Finally, multiple regression
was applied to estimate influences of the individual variables on health-state utilities, using
adjusted odds ratios (ORs).
Ethical considerations
This study was approved by the ethical committee of the Thai Nguyen General Hospital. When
patients were invited to join the study, the purpose was explained to them and they were told
they could choose to join or not, and could stop the interview at any time. Those patients who
did agree to provide the information gave verbal consent to the interviewer.
Results
Main characteristics of patients
The main characteristics of the 712 patients who met the inclusion criteria and joined the
study are presented in Table 1. Patients’ ages ranged from 41 to 80 years; half belonged to the
group 60–69 years and 56% was female. Only 10% of patients still worked for wages. Among
the patients, 66% did not meet their target BP at the time of the survey, while 70% had comor-
bidities and 11% had a history of stroke. The components of comorbidities was presented in S1
Table.
Vietnamese Utilities in Hypertension
PLOS ONE | DOI:10.1371/journal.pone.0139560 October 27, 2015 3 / 9
Health-state utilities
Mean utility was estimated at 0.73 (+/- 0.14) in this hypertensive population. Mean health-
state utilities were significantly different with respect to gender and age groups (all p<0.01).
Table 2 shows that relatively higher BP appeared to be associated with lower health-state utility
at 0.73, 0.73 and 0.71 in the groups with target BP, stage one and stage two, respectively. How-
ever, these differences were not statistically significant (p = 0.42). Regarding comorbidities or
history of stroke, we did not find significant differences between the mean health-state utilities
of these groups (Table 2).
Controlling for other factors with adjusted ORs, we found that utilities in patients from 70
to 80 years old were lower than those of the younger groups; the difference between the oldest
and youngest groups was statistically significant (Table 3; p = 0.03). Health-state utility in
males was higher than in females even after adjustment for other factors (p = 0.002). Patients
with a history of stroke exhibited an apparently lower health-state utility than patients without
stroke, but the difference was not statistically significant (p = 0.79). Patients with more than
three comorbidities had lower utilities than patients with no comorbidity, after adjustment
(p = 0.01).










Being retired or doing housework 637 (89.5)




Stage of BP at the time of survey
Target-BP 242 (34.0)
Stage one 360 (50.6)




History of stroke 78 (11)
Health-state utility
Health-state utility (mean +/- SD (n = 691) 0.73 (+/- 0.14)
Note: Health utility was calculated in 691 patients, as syntax of transferring SF-36 data to utility did not
work in 21 cases (3%) with missing value of any one of the items in the SF-36 form.
doi:10.1371/journal.pone.0139560.t001
Vietnamese Utilities in Hypertension
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Discussion
This study aimed to fill gaps in the evidence on utilities for populations with high BP in low-
and middle-income countries, in particular Vietnam. Accurate utility scores are crucial for a
planned analysis of cost-effectiveness of disease management.
The mean utilities of our population of hypertensive patients are somewhat lower than the
utilities of the general population in Vietnam. For example, the health-state utility of an older
population in a rural community in Vietnam, measured by EQ-5D, was 0.88 while the utility in
our population was 0.73 [20]. However, this comparison should be interpreted with caution as
the studies used different instruments to measure utility [9, 12, 13]. Also, in comparison with
other populations in Asian countries, estimated health-state utility is lower in our hypertensive
population. For example, a general population in Singapore had mean health-state utility of
0.80 (+/-0.12), using the same method for health-state utility measurement [21].
Differences in utilities seem associated with age, gender, and a high number of comorbidi-
ties. However, no such statistically significant differences are found among BP-stages or with
presence of history of stroke. Health-state utility among these hypertensive patients differed
from an Australian study in which the utility of 0.63 was lower than the utility of 0.73 in our
population, using the same instrument and method [22]. However, the population in that
study consisted of prisoners and persons with an impaired mental health status, which may
explain the lower health-state utilities. Results in other studies vary in health-state utility. For
example, health-state utility in a hypertensive population (Beaver Dams study) was 0.72 or
0.83, measured with the Quality of Well-Being (QWB) and time trade-off (TTO) methods,
respectively [13]. In a Swedish population with high BP, health-state utility was 0.73 when
using a rating scale and 0.81 when using TTO [6]. In a Nigerian hypertensive population, it
was relevantly lower at 0.35(+/-0.42), using the HUI3 method [23]. Again, these comparisons
should be interpreted cautiously because different instruments and methods were applied [6].
Finally, in contrast with the aforementioned Nigerian study, in our study, health-state utilities
Table 2. Distribution of health-state utilities by patients’ characteristic (n = 691).









Stage of BP at the time of survey 0.422
Target-BP 0.734 0.14
Stage one 0.726 0.13
Stage two 0.712 0.15
Comorbidity 0.717
No comorbidity 0.729 0.14
Comorbidity(ies) 0.725 0.14
History of stroke 0.729
No stroke 0.727 0.14
Stroke 0.721 0.15
doi:10.1371/journal.pone.0139560.t002
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do not significantly differ for different BP-levels. The methods of analysis between these two
studies differed, with BP specified as a continuous variable in the Nigerian study but as a cate-
gorical one in our study [23]. In addition, in our study BP was measured only once at the time
of examination; we do not know adherence to medication in this population or whether target-
BP was achieved.
As expected, patients with a history of stroke have lower utilities than those without such a
history in our study, however lacking statistical significance (likely due to relatively small num-
bers) [23]. Our finding that history of stroke does not significantly predicts utilities in our
study population is in line with a similar study in a Swedish population [6]. Next to small num-
bers, a further reason may be that severity of health impacts and complications after stroke
were relatively mild and all patients generally recovered.
In general, older patients have lower utilities than younger ones in our study. When control-
ling for sex and health status, the only significant difference found is between the oldest group
and youngest group. Obviously and in general, utility decreases with age and in other studies it
has indeed been quantified that each year of increasing age was reported to reduce health-state
utility [22, 23]. In line with other studies, males have 0.03 higher mean health-state utility than
females [22, 23]. We find an association between comorbidities and utilities, but this associa-
tion is only manifest for patients having more than three comorbidities. In the Australian
study, researchers reported that each increase in the number of comorbidities was associated
with reduced utility [22]. It should be noted that our results appear without controlling for
other variables that may affect HRQoL, such as body mass index, educational level, smoking,
marital status, income/socioeconomic factors, serious events in the past, antihypertensive
drugs, household position and awareness of hypertension [5, 9, 11, 20, 22, 24–27].
Table 3. Predictors of health-state utilities in hypertensive patients (n = 691).
OR 95% CI p
Lower bound Upper bound
Age (years)
41–49 (ref)
50–59 -0.04 -0.12 0.04 0.34
60–69 -0.06 -0.13 0.02 0.16
70–80 -0.09 -0.17 -0.01 0.03
Sex
Male (ref)
Female -0.03 -0.05 -0.01 0.002
Stage of BP at the time of survey
Target-BP (ref)
BP Stage one -0.01 -0.03 0.01 0.43
BP stage two -0.02 -0.05 0.02 0.32
Stroke
No history of stroke (ref)
History of stroke -0.004 -0.04 0.03 0.79
Comorbidity
No comorbidity (ref)
One comorbidity 0.01 -0.02 0.03 0.53
Two comorbidities -0.004 -0.03 0.03 0.81
Three comorbidities -0.04 -0.08 0.02 0.20
> Three comorbidities -0.11 -0.18 -0.03 0.01
doi:10.1371/journal.pone.0139560.t003
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Regarding the limitations of the study, it should be mentioned that reliability and validity of
applying the equation to obtain utilities from SF-36 in Vietnam should be investigated further,
as it was developed for a Western population. We should be aware of potential similar prob-
lems as reported for other instruments [28, 29]. However, it has already been used in other
Asian countries [21, 30] and currently does seem the optimal approach, most likely being
acceptable for our measurements. In Vietnam, hypertension also occurs below the age of 40
years. However, we limited our study to 40 and over as younger patients were not available in
the survey. Despite specific questions in the questionnaire, we were unable to get reliable esti-
mates on the exact number of years since diagnosis of hypertension. Patients seemed unable to
exactly recall year of diagnosis. Therefore, an analysis on the relationship between health utili-
ties, duration, seriousness of progressive disease and burden of comorbidities overtime could
not be performed in this study. Finally, due to scarce resources, capacity and funds, data collec-
tion lasted only two months, which may have influenced the type of patients included with
respect to how they managed their hypertension in this specific hospital.
Conclusions
Health-state utilities found among hypertensive patients in Vietnam were similar to those
found in other international studies. It is suggested that lower of health-state utilities exist
among those patients who were older, female or had more than three comorbidities in compar-
ison with respective reference groups. However, further research for confirmation is required.
The data from this study provide a potential reference on health-state utilities of hypertensive
patients in Vietnam as an input for future cost-effectiveness analysis of interventions. Also, it
may serve as a reference for other similar populations, especially in the context of similar envi-
ronments in low income countries.
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